Abstract
BackgroundSeveral studies have suggested that obesity could have a negative influence on the response to anti-TNFα, including infliximab, in rheumatoid arthritis (RA) and spondyloarthritis. Little is known about the impact...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have